TRYP Therapeutics Inc TRYPF:OTCQB

RT Quote | Exchange | USD
Last | 9:42 AM EDT
0.093UNCH (UNCH)
Volume
2,210
52 week range
0.05 - 0.54
Loading...
  • Open0.1042
  • Day High0.1042
  • Day Low0.093
  • Prev Close0.093
  • 52 Week High0.54
  • 52 Week High Date08/02/21
  • 52 Week Low0.05
  • 52 Week Low Date05/02/22

Key Stats

  • Market Cap5.02M
  • Shares Out71.85M
  • 10 Day Average Volume109,828.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-57.14

KEY STATS

  • Open0.1042
  • Day High0.1042
  • Day Low0.093
  • Prev Close0.093
  • 52 Week High0.54
  • 52 Week High Date08/02/21
  • 52 Week Low0.05
  • 52 Week Low Date05/02/22
  • Market Cap5.02M
  • Shares Out71.85M
  • 10 Day Average Volume109,828.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-57.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.12
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TRYP Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Tryp Therapeutics Inc. is a Canada-based pharmaceutical company. The Company is focused on developing psilocybin-based compounds for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The Company’s lead development program, Psilocybin-For-Neuropsychiatric Disorders (PFN) program, is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. The primary indications for its PFN are in the...
Address
c/o Pushor Mitchell LLP
301 - 1665 Ellis Street
Kelowna, BC
V1Y 2B3
Canada